Cervical cancer is one of the most common malignancies worldwide, yet it is clearly preventable by population screening. It has been reported that <5% of women in underdeveloped countries have ever had a Pap test. That is due to shortage of medical resources, shortage of pathologists and cytotechnologists and the limited public awareness regarding screening programs. Some believe that the disease has reached an epidemic proportion with huge human and economic impact that is requiring immediate, innovative practical solutions. Even with the hope of HPV vaccination and the current push for HPV testing as a primary screening method, Pap smear remains to be the best cancer screening method known to mankind. The invention is a new method of using automated cellblock (CB) preparations of liquid-based [ThinPrep + SurePath] and conventional samples to produce virtual slides.
To learn more about the technology a published paper (pdf) is available for download.